PAR 1.79% 27.5¢ paradigm biopharmaceuticals limited..

Paradigm patent rejection, page-10

  1. 572 Posts.
    lightbulb Created with Sketch. 55
    lol. love how the usual suspects say IP is rock solid then something like this comes out and now its of no concern and the bene agreement is as good as, if not better than actual IP. Again, another example of the culture in PAR to lay silent on negative developments. its actually becoming laughable. its now just becoming a science project with no commercial outcome.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.